214 related articles for article (PubMed ID: 3245731)
1. Cardioselective effects of gallopamil compared with verapamil in the dog heart.
Takahashi K; Tsuchida K; Aihara H
Arch Int Pharmacodyn Ther; 1988; 295():157-73. PubMed ID: 3245731
[TBL] [Abstract][Full Text] [Related]
2. Selectivity of alinidine, a bradycardic agent, for SA nodal automaticity versus other cardiac activities in isolated, blood-perfused dog-heart preparations.
Kawada M; Satoh K; Taira N
Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):88-102. PubMed ID: 6517649
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of coronary vasodilator and cardiac effects of nitrendipine by use of isolated, blood-perfused dog heart preparations.
Satoh K; Wada Y; Taira N
Arzneimittelforschung; 1986; 36(1):35-9. PubMed ID: 2937413
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular profiles of the calcium antagonists nisoldipine and nifedipine in the blood-perfused dog heart.
Takahashi K; Taira N
Arzneimittelforschung; 1986 Jul; 36(7):1054-9. PubMed ID: 3768072
[TBL] [Abstract][Full Text] [Related]
5. Analyses of the cardiac action of the bradycardic agent, AQ-A 39, by use of isolated, blood-perfused dog-heart preparations.
Kawada M; Satoh K; Taira N
J Pharmacol Exp Ther; 1984 Feb; 228(2):484-90. PubMed ID: 6694121
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular actions of the dihydropyridine calcium antagonist nimodipine in the dog.
Satoh K; Kawada M; Wada Y; Taira N
Arzneimittelforschung; 1984; 34(5):563-8. PubMed ID: 6540573
[TBL] [Abstract][Full Text] [Related]
7. Profile of coronary vasodilator and cardiac actions of bepridil revealed by use of isolated, blood-perfused heart preparations of the dog.
Kawada M; Satoh K; Taira N
J Cardiovasc Pharmacol; 1983; 5(4):604-12. PubMed ID: 6193358
[TBL] [Abstract][Full Text] [Related]
8. Coronary vasodilator and cardiac effects of NKY-722, a novel hydrophilic 1,4-dihydropyridine derivative, in the blood-perfused dog heart.
Imagawa J; Satoh K; Taira N
Cardiovasc Drugs Ther; 1989 Mar; 3(1):81-90. PubMed ID: 2487526
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular profile of Ro 40-5967, a new nondihydropyridine calcium antagonist, delineated in isolated, blood-perfused dog hearts.
Orito K; Satoh K; Taira N
J Cardiovasc Pharmacol; 1993 Aug; 22(2):293-9. PubMed ID: 7692172
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous assessment of the effects of trimetazidine on the myocardium and coronary vasculature of the dog.
Yanagisawa T; Satoh K; Taira N
Arch Int Pharmacodyn Ther; 1979 Feb; 237(2):316-29. PubMed ID: 485693
[TBL] [Abstract][Full Text] [Related]
11. Coronary vasodilator compared to cardiac effects of PY 108-068, a new dihydropyridine vasodilator, on isolated, blood-perfused dog-heart preparations.
Wada Y; Satoh K; Taira N
J Cardiovasc Pharmacol; 1984; 6(5):881-7. PubMed ID: 6209495
[TBL] [Abstract][Full Text] [Related]
12. Cardiac versus coronary dilator effects of SD-3211, a new nondihydropyridine calcium antagonist, in isolated, blood-perfused dog hearts.
Yoneyama F; Yamada H; Satoh K; Taira N
Cardiovasc Drugs Ther; 1990 Dec; 4(6):1469-76. PubMed ID: 2081139
[TBL] [Abstract][Full Text] [Related]
13. Are the cardiovascular effects of gentamicin similar to those of calcium antagonists?
Gotanda K; Yanagisawa T; Satoh K; Taira N
Jpn J Pharmacol; 1988 Jul; 47(3):217-27. PubMed ID: 3221528
[TBL] [Abstract][Full Text] [Related]
14. Separation of the coronary vasodilator from the cardiac effects of PN 200-110, a new dihydropyridine calcium antagonist, in the dog heart.
Wada Y; Satoh K; Taira N
J Cardiovasc Pharmacol; 1985; 7(1):190-6. PubMed ID: 2580142
[TBL] [Abstract][Full Text] [Related]
15. Cardiac versus coronary vasodilator actions of KB-944, a new calcium antagonist, assessed in isolated, blood-perfused heart preparations of dogs.
Taira N; Kawada M; Satoh K
J Cardiovasc Pharmacol; 1983; 5(3):349-56. PubMed ID: 6191131
[TBL] [Abstract][Full Text] [Related]
16. Coronary vasodilator versus cardiac effects of MCI-176, a novel quinazolinone calcium antagonist, in the dog heart.
Hosono M; Taira N
J Cardiovasc Pharmacol; 1987 Jun; 9(6):633-40. PubMed ID: 2442528
[TBL] [Abstract][Full Text] [Related]
17. Inotropic versus chronotropic, dromotropic, and coronary vasodilator actions of DPI 201-106, a novel positive inotropic agent, in the dog heart.
Takahashi K; Endoh M; Taira N
J Cardiovasc Pharmacol; 1987 Apr; 9(4):451-60. PubMed ID: 2438508
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular profile of AN-132, a new diamine derivative antiarrhythmic agent, revealed in the isolated, blood-perfused dog heart.
Gotanda K; Satoh K; Taira N
Tohoku J Exp Med; 1988 Sep; 156(1):65-78. PubMed ID: 3194907
[TBL] [Abstract][Full Text] [Related]
19. Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3(2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs.
Ishimori T; Gotanda K; Sasaki T; Shinbo A; Asano H; Miyazawa K; Miyasaka K
Arzneimittelforschung; 1994 May; 44(5):583-8. PubMed ID: 7912931
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of MDL 17043 and MDL 19205, new positive inotropic agents, by use of isolated, blood-perfused dog-heart preparations.
Wada Y; Taira N
Heart Vessels; 1986; 2(1):29-35. PubMed ID: 2941407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]